ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
March 07, 2022 16:48 ET
|
The Rosen Law Firm PA
NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021...
DEADLINE ALERT for TLS, ASTR, FENC, AFIB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
March 01, 2022 12:00 ET
|
Law Offices of Howard G. Smith
BENSALEM, Pa., March 01, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Acutus Medical, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
February 26, 2022 09:21 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 26, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acutus Medical, Inc. (NASDAQ: AFIB) between May 13, 2021...
ROSEN, A LONGSTANDING LAW FIRM, Encourages Acutus Medical, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AFIB
February 22, 2022 14:20 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Acutus...
BioSig Awarded US Patent Claims for its PURE EP™ Noise-Filtering Technology
January 26, 2022 13:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Claims address computer-implemented systems and methods for filtering noise from input cardiac signals using its PURE EP™ technologyThe Company now...
BioSig to Present at the 27th Annual International AF Symposium
January 07, 2022 10:20 ET
|
BioSig Technologies, Inc.
Westport, CT, Jan. 07, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing...
BioSig to Present at the 24th Annual Virtual Needham Growth Conference
January 06, 2022 08:30 ET
|
BioSig Technologies, Inc.
Westport, CT, Jan. 06, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
Data on Gencaro Impact on Prevention of Bradycardia Published in Heart Rhythm O2
January 04, 2022 08:30 ET
|
ARCA biopharma, Inc.
Clinically important bradycardia is common in heart failure (HF) patients with persistent or paroxysmal atrial fibrillation (AF)In a Phase 2B clinical trial, the prevalence of clinically important...
BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales
December 21, 2021 09:00 ET
|
BioSig Technologies, Inc.
Westport, CT, Dec. 21, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...
BioSig Expands Its Clinical Footprint In Florida
December 16, 2021 09:15 ET
|
BioSig Technologies, Inc.
Westport, CT, Dec. 16, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing...